SCHEMBL4789433

SCHEMBL4789433

O=C(O)CCCN1CCC[C@@H](OCc2ccccc2)C1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRNB2 P17787 2/20 0.53
▸ CHRNB4 P30926 2/20 0.53
▸ CHRNA3 P32297 2/20 0.53
▸ CHRNA4 P43681 2/20 0.53
▸ DRD2 P14416 1/20 0.52
▸ DRD3 P35462 1/20 0.52
▸ KCNH2 Q12809 1/20 0.52
▸ BCHE P06276 5/20 0.50
▸ ALDH1A1 P00352 2/20 0.49
▸ LMNA P02545 1/20 0.49
▸ MAPK1 P28482 1/20 0.49
▸ KDM4E B2RXH2 4/20 0.49
▸ KMT2A Q03164 1/20 0.49
▸ NPC1 O15118 3/20 0.47
▸ RAB9A P51151 3/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ MAOB P27338 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21198787 0.93 BCHE (0.58) CHRNB2CHRNB4CHRNA3CHRNA4BCHE
SCHEMBL21198788 0.93 BCHE (0.58) CHRNB2CHRNB4CHRNA3CHRNA4BCHE
SCHEMBL28489345 0.91 BCHE (0.57) CHRNB2CHRNB4CHRNA3CHRNA4BCHE
SCHEMBL28489343 0.91 BCHE (0.57) CHRNB2CHRNB4CHRNA3CHRNA4BCHE
SCHEMBL1787933 0.89 CHRNB2 (0.50) CHRNB2CHRNB4CHRNA3CHRNA4DRD2
Lithium Ion SCHEMBL29789468 0.82 BCHE (0.55) CHRNB2CHRNB4CHRNA3CHRNA4BCHE
SCHEMBL27741092 0.81 DRD2 (0.50) CHRNB2CHRNB4CHRNA3CHRNA4DRD2
SCHEMBL21206426 0.79 BCHE (0.54) BCHEL3MBTL1TMEM97SIGMAR1
SCHEMBL28485695 0.79 BCHE (0.54) BCHEL3MBTL1TMEM97SIGMAR1
SCHEMBL19779511 0.79 ALDH1A1 (0.63) DRD2DRD3KCNH2BCHEALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008131859-A2 USE OF CYCLICALLY SUBSTITUTED FUROPYRIMIDINE DERIVATIVES FOR TREATING PULMONARY ARTERIAL HYPERTONIA BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-11-06 — — WO disclosed
Send feedback